A detailed history of Laurion Capital Management LP transactions in Pyxis Oncology, Inc. stock. As of the latest transaction made, Laurion Capital Management LP holds 3,861,179 shares of PYXS stock, worth $14.6 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
3,861,179
Previous 3,861,179 -0.0%
Holding current value
$14.6 Million
Previous $16.4 Million 22.3%
% of portfolio
0.15%
Previous 0.14%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$2.03 - $6.59 $1.4 Million - $4.55 Million
690,376 Added 21.77%
3,861,179 $16.4 Million
Q2 2022

Aug 15, 2022

BUY
$2.02 - $4.53 $3.94 Million - $8.84 Million
1,950,971 Added 159.94%
3,170,803 $7.55 Million
Q1 2022

May 16, 2022

BUY
$4.04 - $11.43 $232,300 - $657,225
57,500 Added 4.95%
1,219,832 $4.93 Million
Q4 2021

Feb 14, 2022

BUY
$8.39 - $13.64 $9.75 Million - $15.9 Million
1,162,332 New
1,162,332 $12.8 Million

Others Institutions Holding PYXS

About Pyxis Oncology, Inc.


  • Ticker PYXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,096,400
  • Market Cap $132M
  • Description
  • Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...
More about PYXS
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.